Further Novel Forms Of Interfering Rna Molecules

Patent No. EP1857547 (titled "Further Novel Forms Of Interfering Rna Molecules") was filed by Atugen on Aug 5, 2003. The application was issued on Dec 2, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANOFIOct 17, 2018MATHYS & SQUIRE
THE MEDICINES UKOct 16, 2018BIRD & BIRD
ALNYLAM PHARMACEUTICALSAug 17, 2018POTTER CLARKSON

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1857547

ATUGEN
Application Number
EP06027129A
Filing Date
Aug 5, 2003
Status
Patent Maintained As Amended
Oct 30, 2020
Publication Date
Dec 2, 2020